chartexchange

Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

GlobeNewswire Inc. | Nov 13, 2026 8:00 AM EST

FDA lifted clinical hold on ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS)

Read original article